Brandhorst H, Brandhorst D, Hering B J, Bretzel R G
Third Medical Department, Justus-Liebig-University, Giessen, Germany.
Transplantation. 1999 Aug 15;68(3):355-61. doi: 10.1097/00007890-199908150-00006.
Frequent success in human islet isolation is prevented by the large variability of scarce organ donors; this favors the future utilization of pigs as donors for clinical islet xenotransplantation. Porcine-specific difficulties of islet isolation are attributed to the intrinsic fragility of islets during pancreas digestion.
To preserve islet integrity during efficient pancreas dissociation, porcine pancreata (n=48) were distended after cold storage with cold University of Wisconsin solution containing Liberase HI and digested at 24-28 degrees C using digestion-filtration. Pancreata distended with University of Wisconsin solution containing well-proven crude collagenase and digested at 32-34 degrees C served as controls (n=46). Monolayer Ficolldiatrizoate gradient purification was performed in a Cobe 2991.
Purified yield of islet equivalents per pancreas (mean+/-SEM) was almost doubled by Liberase HI compared with crude collagenase (526,480+/-46,560 vs. 270,270+/-19,420; P < 0.0001) and also significantly increased comparing islet equivalents per gram of pancreas (4,210+/-320 vs. 2,640+/-245; P=0.0004). Islet integrity was better preserved during Liberase HI digestion compared with crude collagenase digestion as indicated by isolation index (2.1+/-0.1 vs. 1.4+/-0.1; P<0.0001). Purity, viability, and in vitro function of islets did not differ between experimental groups. Preserved in vivo function of islets isolated by Liberase HI was demonstrated after subcapsular transplantation into 16 diabetic nude rats.
If the problems related to xenograft rejection and xenosis could be solved, low-temperature digestion of porcine pancreata using Liberase HI could serve as an essential prerequisite for successful 1:1 xenotransplantation of pig islets into type 1 diabetic human recipients.
稀缺器官供体的巨大变异性阻碍了人类胰岛分离的频繁成功;这有利于未来将猪用作临床胰岛异种移植的供体。胰岛分离中猪特有的困难归因于胰腺消化过程中胰岛的内在脆弱性。
为了在高效胰腺解离过程中保持胰岛完整性,将48个猪胰腺在冷保存后用含 Liberase HI 的冷威斯康星大学溶液膨胀,并在24 - 28摄氏度下使用消化 - 过滤法进行消化。用含久经证实的粗制胶原酶的威斯康星大学溶液膨胀并在32 - 34摄氏度下消化的胰腺作为对照(n = 46)。在Cobe 2991中进行单层聚蔗糖 - 泛影葡胺梯度纯化。
与粗制胶原酶相比,Liberase HI 使每个胰腺的纯化胰岛当量产量(平均值±标准误)几乎翻倍(526,480±46,560对270,270±19,420;P < 0.0001),并且每克胰腺的胰岛当量也显著增加(4,210±320对2,640±245;P = 0.0004)。如分离指数所示,与粗制胶原酶消化相比,Liberase HI 消化过程中胰岛完整性得到更好的保留(2.1±0.1对1.4±0.1;P < 0.0001)。实验组之间胰岛的纯度、活力和体外功能没有差异。将通过 Liberase HI 分离的胰岛包膜下移植到16只糖尿病裸鼠后,证明了其体内功能得以保留。
如果与异种移植排斥和异种病相关的问题能够得到解决,使用 Liberase HI 对猪胰腺进行低温消化可能是将猪胰岛成功1:1异种移植给1型糖尿病人类受者的必要前提。